Ligand Pharmaceuticals, Inc. (LGND)


Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Ligand Pharmaceuticals, Inc. chart...

About the Company

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

CEO

John Higgins

Exchange

NASDAQ

Website

https://www.ligand.com/

$56M

Total Revenue

130

Employees

$1B

Market Capitalization

50.04

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $LGND News

Q4 2023 Ligand Pharmaceuticals Inc Earnings Call

20d ago, source: Yahoo Finance

Ladies and gentlemen, thank you for standing by, and welcome everyone to the Ligand Fourth Quarter 2023 earnings webcast. At this time, all lines have been placed on mute to prevent any background ...

Ligand Pharmaceuticals Inc Q4 Earnings Summary

21d ago, source: Business Insider

(RTTNews) - Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND): Earnings: $18.19 million in Q4 vs. -$17.49 million in the same period last year. EPS: $1.03 in Q4 vs.

Ligand: Q4 Earnings Snapshot

20d ago, source: The Washington Post

SAN DIEGO — SAN DIEGO — Ligand Pharmaceuticals Inc. (LGND) on Tuesday reported net income of $18.2 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had ...

Ligand Pharmaceuticals Inc (LGND) Reports Solid Earnings Amidst Operational Transformation

21d ago, source: Yahoo Finance

Warning! GuruFocus has detected 6 Warning Signs with LGND. Ligand Pharmaceuticals Inc (NASDAQ:LGND) released its 8-K filing on February 27, 2024, detailing its financial results for the fourth ...

Ligand Pharmaceuticals Inc. (LGND) Q4 2023 Earnings Call Transcript

20d ago, source: Seeking Alpha

Ladies and gentlemen, thank you for standing by. Welcome everyone to the Ligand Fourth Quarter 2023 Earnings Webcast. At this time, all lines have been placed on mute to prevent any background noise.

Ligand Pharmaceuticals Inc LGND

22d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Q4 2023 Ligand Pharmaceuticals Inc Earnings Call

20d ago, source: 雅虎財經

Ladies and gentlemen, thank you for standing by, and welcome everyone to the Ligand Fourth Quarter 2023 earnings webcast ... Rylaze is marketed by our partner, Jazz Pharmaceuticals as a component of a ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...